Diabetic Foot Ulcers Treatment Market by Ulcer Type (Neuropathic Ulcers, and Neuro-Ischemic Ulcers); by Product Type (Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings), Biologics (Growth factors, and Skin Graft and Skin Substitute), Therapy Devices (Negative pressure wound devices, Hyperbaric Oxygen therapy devices, and Other Therapy Devices), and Other Products); by End User (Hospital, Clinics, Ambulatory Surgical Center, and Homecare Setting) and by Geography - Global Trends and Forecast to 2025
- Report code : CMI61357 |
- Industry :
Pharmaceutical
- Published On : Mar 2018 |
- Pages : 173 Pages |
- Format :
Diabetic Foot Ulcers Treatment Market – Insights
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the patients with diabetes mellitus and diabetes insipidus, which also leads to chronic foot wounds due to minor trauma or pressure. The treatment for diabetic foot ulcers is divided into five stages: stage 1, which is a normal foot; stage 2, high risk foot; stage 3, an ulcerated foot; stage 4, an infected foot; and stage 5, a necrotic foot. It is important to prevent the development of diabetic foot ulcers in stage 1 and 2 while stage 3 require urgent treatment management for foot ulcers.
Rising prevalence of diabetes is a major factor driving growth of the diabetic foot ulcers treatment market. As According to WHO, The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. According to a report published by Center for Disease Control and Prevention in 2017, over 100 million of the adults in the U.S. are suffering from prediabetes or diabetes. The report has also stated that another 84.1 million have prediabetes conditions, which if not treated may lead to type 2 diabetes within five years. Furthermore, the CDC stated that between 60% and 70% of the people with diabetes suffers from diabetic neuropathy annually, where the nerves of the feet and legs are mostly affected.
The global diabetic foot ulcers treatment market was valued at US$ 1,209.4 million in 2017 and is expected to witness a robust CAGR of 9.4% over the forecast period (2017–2025).
Global Diabetic Foot Ulcers Treatment Market Value (US$ Mn), By Region - 2017
SOURCE: COHERENT MARKET INSIGHTS ANALYSIS (2017)
Rising prevalence of diabetes is expected to favor growth of the diabetic foot ulcers treatment market in the near future
North America accounted for the largest share in the global diabetic foot ulcers treatment market, followed by Europe, in 2017. This is attributed to increasing prevalence of diabetes in North America. According to Center for Disease Control and Prevention, diabetes was the seventh leading cause of death in the U.S. in 2015 and 1.5 million new cases of diabetes were diagnosed among people aged 18 years and older.
Furthermore, CDC partnered with various organizations to launch programs to create awareness about diabetes. For instance, CDC established National Diabetes Prevention Program in 2010, which provides a framework to prevent or delay type 2 diabetes efforts in the U.S., where this program is still active and effective.
In Asia Pacific region, the diabetic foot ulcers treatment market is expected to exhibit a high growth rate over the forecast period. This is owing to increasing number of population suffering from diabetes. For instance, according to The International Diabetes Federation, there were 382 million people with diabetes in 2013, of which over 60% of the people live in Asia, with almost half in China and India combined.
Technological advancement in treatment of diabetic foot ulcers is expected to drive growth of the diabetic foot ulcers treatment market.
Introduction of several novel wound healing agents, which are administrated as a topical ointment or spray or injected directly into the wound is expected to favor growth of the diabetic foot ulcers treatment market. For instance, in August 2017, ViroMed started phase III trial of its VM202 gene therapy for non-healing diabetic foot ulcers and concomitant peripheral artery disease (PAD).
Furthermore, development of various device such as shock wave, for the treatment of diabetic foot ulcers is also expected to favor growth of the diabetic foot ulcers treatment market in the near future. For instance, in December 2017, the U.S. Food and Drug Administration gave approval for marketing of SANUWAVE Health, Inc., Dermapace System, which is a first shock wave device intended to treat diabetic foot ulcers.
Some major players operating in the global diabetic foot ulcers treatment market include 3M Healthcare, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew Plc., Medtronic Plc, ConvaTec Inc, and Mölnlycke Health Care.
Diabetic foot ulcers is a common disease observed in diabetic patients. According to facts presented in fact sheet 2017, Center for Disease and Prevention, among the total diabetic population, 60%–80% suffers from foot ulcers. New and innovative treatments in wound dressings and therapy devices is expected to augment the diabetic foot ulcers treatment market growth. Since there are less availability of products to treat diabetic foot ulcers by device, provides a great opportunity for key players as well as new entrants to enter the diabetic foot ulcers treatment market. Furthermore, Negative pressure wound therapy devices essential for the management of diabetic foot ulcers, as also expected to favor the growth of diabetic foot ulcers treatment market.
Market Dynamics
Diabetic foot ulcers treatment market is mainly driven by increasing prevalence of diabetes. According to World Health Organization, it was estimated that 422 million adults were suffering from diabetes, in 2014 globally. Furthermore, according to National Diabetes Statistics Report 2017, 30.3 million people in the U.S. have been estimated to have diabetes. This is expected to favor growth of the diabetic foot ulcers treatment market.
Furthermore, according to the data published by Agency for Healthcare Research & Quality (AHRQ) in October 2014, over 2.5 million individuals in the U.S. develop pressure ulcers annually, which costs the U.S. health care system around US$ 9.1 billion to US$ 11.6 billion per year
Increasing number of product launches and innovative therapies are also expected to drive the diabetic foot ulcers treatment market growth. For instance, in December 2017, FDA approved shockwave therapy by Dermapace for diabetic foot ulcers treatment. The FDA also approved a spray, Granulox by infirst Healthcare Ltd, in November 2017, for the treatment of diabetic foot ulcers.
Key features of the study:
- This report provides an in-depth analysis of global diabetic foot ulcers treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global diabetic foot ulcers treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
- Key companies covered as a part of this study include 3M Healthcare Ltd, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew Plc., Medtronic Plc, and ConvaTec Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global diabetic foot ulcers treatment market report caters to various stakeholders in this industry including investors, suppliers, diabetic foot ulcers treatment manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the diabetic foot ulcers treatment market
Detailed Segmentation:
- Global Diabetic Foot Ulcers Treatment Market, By Ulcers:
- Neuropathic Ulcers
- Neuro-Ischemic Ulcers
- Global Diabetic Foot Ulcers Treatment Market, By Product Type:
- Wound Care Dressings
- Foam Dressing
- Hydrocolloid Dressing
- Hydrogel Dressing
- Alginate Dressing
- Other Dressing
- Biologics
- Growth factors
- Skin Graft and Skin Substitutes
- Wound Care Therapy Devices
- Negative Pressure Wound Devices
- Hyperbaric Oxygen Therapy
- Other Wound Care Therapy Devices
- Others
- Global Diabetic Foot Ulcers Treatment Market, By End User:
- Hospital
- Clinics
- Ambulatory Surgical Center
- Homecare Setting
- Global Diabetic Foot Ulcers Treatment Market, By Geography:
- North America
- By Ulcers:
- Neuropathic Ulcers
- Neuro-Ischemic Ulcers
- By Product Type:
- Wound Care Dressings
- Foam Dressing
- Hydrocolloid Dressing
- Hydrogel Dressing
- Alginate Dressing
- Other Dressing
- Biologics
- Growth factors
- Skin Graft and Skin Substitutes
- Wound Care Therapy Devices
- Negative Pressure Wound Devices
- Hyperbaric Oxygen Therapy
- Other Wound Care Therapy Devices
- Others
- By End User
- Hospital
- Clinics
- Ambulatory Surgical Center
- Homecare Setting
- By Country
- U.S.
- Canada
- Europe
- By Ulcers:
- Neuropathic Ulcers
- Neuro-Ischemic Ulcers
- By Product Type:
- Wound Care Dressings
- Foam Dressing
- Hydrocolloid Dressing
- Hydrogel Dressing
- Alginate Dressing
- Other Dressing
- Biologics
- Growth factors
- Skin Graft and Skin Substitutes
- Wound Care Therapy Devices
- Negative Pressure Wound Devices
- Hyperbaric Oxygen Therapy
- Other Wound Care Therapy Devices
- Others
- By End User
- Hospital
- Clinics
- Ambulatory Surgical Center
- Homecare Setting
- By Country
- U.K.
- Germany
- Italy
- France
- Russia
- Spain
- Rest of Europe
- Asia Pacific
- By Ulcers:
- Neuropathic Ulcers
- Neuro-Ischemic Ulcers
- By Product Type:
- Wound Care Dressings
- Foam Dressing
- Hydrocolloid Dressing
- Hydrogel Dressing
- Alginate Dressing
- Other Dressing
- Biologics
- Growth factors
- Skin Graft and Skin Substitutes
- Wound Care Therapy Devices
- Negative Pressure Wound Devices
- Hyperbaric Oxygen Therapy
- Other Wound Care Therapy Devices
- Others
- By End User
- Hospital
- Clinics
- Ambulatory Surgical Center
- Homecare Setting
- By Country
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Ulcers:
- Neuropathic Ulcers
- Neuro-Ischemic Ulcers
- By Product Type:
- Wound Care Dressings
- Foam Dressing
- Hydrocolloid Dressing
- Hydrogel Dressing
- Alginate Dressing
- Other Dressing
- Biologics
- Growth factors
- Skin Graft and Skin Substitutes
- Wound Care Therapy Devices
- Negative Pressure Wound Devices
- Hyperbaric Oxygen Therapy
- Other Wound Care Therapy Devices
- Others
- By End User
- Hospital
- Clinics
- Ambulatory Surgical Center
- Homecare Setting
- By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- By Ulcers:
- Neuropathic Ulcers
- Neuro-Ischemic Ulcers
- By Product Type:
- Wound Care Dressings
- Foam Dressing
- Hydrocolloid Dressing
- Hydrogel Dressing
- Alginate Dressing
- Other Dressing
- Biologics
- Growth factors
- Skin Graft and Skin Substitutes
- Wound Care Therapy Devices
- Negative Pressure Wound Devices
- Hyperbaric Oxygen Therapy
- Other Wound Care Therapy Devices
- Others
- By End User
- Hospital
- Clinics
- Ambulatory Surgical Center
- Homecare Setting
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Ulcers:
- Neuropathic Ulcers
- Neuro-Ischemic Ulcers
- By Product Type:
- Wound Care Dressings
- Foam Dressing
- Hydrocolloid Dressing
- Hydrogel Dressing
- Alginate Dressing
- Other Dressing
- Biologics
- Growth factors
- Skin Graft and Skin Substitutes
- Wound Care Therapy Devices
- Negative Pressure Wound Devices
- Hyperbaric Oxygen Therapy
- Other Wound Care Therapy Devices
- Others
- By End User
- Hospital
- Clinics
- Ambulatory Surgical Center
- Homecare Setting
- By Country
- North Africa
- Central Africa
- South Africa
- Company Profiles
- 3M Healthcare Ltd*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Future Plans
- Coloplast A/S
- B.Braun Melsungen AG
- Medtronic plc.
- Acelity L.P. Inc.
- Smith & Nephew Plc.
- ConvaTec Inc.
- Mölnlycke Health Care
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Ulcer Type
- Market Snippet, By Product Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Epidemiology
- Technological Trends
- PEST Analysis
- Global Diabetic Foot Ulcers Treatment Market, By Ulcers, 2015–2025 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2015–2025
- Segment Trends
- Neuropathic Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Neuro-Ischemic Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Global Diabetic Foot Ulcers Treatment Market, By Product Type, 2015–2025 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Wound Care Dressings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Foam Dressing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Hydrocolloid Dressing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Hydrogel Dressing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Alginate Dressing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Other Dressing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Growth Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Skin Graft and Skin Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Growth Factors
- Therapy Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Negative Pressure Wound Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Hyperbaric Oxygen Therapy Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Other Wound Care Therapy Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Negative Pressure Wound Devices
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Global Diabetic Foot Ulcers Treatment Market, By End User, 2015–2025 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Ambulatory Surgical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Homecare Setting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million )
- Global Diabetic Foot Ulcers Treatment Market, By Regions, 2015–2025 (US$ Million )
- Introduction
- Market Share Analysis, By Region, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, For Regions, 2016–2025
- North America
- Market Size and Forecast, By Ulcer Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Ulcer Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Ulcer Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Latin America
- Market Size and Forecast, By Ulcer Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Ulcer Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Ulcer Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- 3M Healthcare Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Coloplast A/S
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- B.Braun Melsungen AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Medtronic plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Acelity L.P. Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Smith & Nephew Plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- ConvaTec Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Mölnlycke Health Care
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 45 market data tables and 40 figures on "Diabetic Foot Ulcers Treatment Market” - Global forecast to 2025”.
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.